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Purpose: To estimate whether the city-specific lockdown in Shanghai induced by the
COVID-19 pandemic affected preterm birth rates among uninfected pregnant women in
different trimesters.
Methods: The population-based retrospective cohort study was conducted in the
International Peace Maternity and Child Health Hospital (IPMCH) in Shanghai, China.
Pregnant women without COVID-19 received perinatal healthcare during lockdown (from
January 24, 2020 to March 24, 2020) and non-lockdown (from January 24, 2019 to
March 24, 2019) period and giving birth to a live infant at IPMCH were enrolled. 1:1
propensity score matching and Inverse probability of treatment weighting were used to
evaluate preterm birth (<37 weeks), very preterm birth (<34 weeks), preterm birth with
premature rupture of membranes (PROM-PTB), spontaneous preterm birth with intact
membranes (S-PTB), andmedically induced preterm birth (MI-PTB) between two groups.
Results: 8,270 pregnant women were in the lockdown group, and 9,815 were in
the non-lockdown group. Pregnant women in second trimester during lockdown had a
higher risk of PTB than those during the non-lockdown period [OR: 1.43 (CI 1.01–2.02),
ARD: 1.7% (CI 0.04–3.4%), p = 0.045]. Furthermore, pregnant women in third trimester
during lockdown had a higher risk of PROM-PTB than those during the non-lockdown
period [OR: 1.64 (CI 1.09–2.47), ARD: 0.9% (CI 0.2–1.6%), p = 0.02]; no group
differences were found related to rates of VPTB, S-PTB or MI-PTB.
Conclusion: In this cohort study in China, we found that there was an increased
risk in preterm birth for non-infected women in COVID-19 lockdown who were in their
second trimester.
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INTRODUCTION
Coronavirus disease 2019 (COVID-19) is a highly infectious disease with a significant mortality
rate that has limited effective treatment options (1). In late 2019, hospitals in Wuhan City in Hubei
Province admitted multiple patients with unexplained pneumonia with a history of exposure to
the South China Seafood Market, and these cases of pneumonia have since been confirmed as
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COVID-19. COVID-19 was officially identified as a type B
infectious disease with human-to-human transmission by the
National Health Council on January 20, 2020 (2). Due to the
high contagiousness of COVID-19 and the population’s general
susceptibility, a city-wide lockdown was declared in Shanghai on
January 24, 2020 and ended on March 24 (3), 2020. During the
lockdown, (1) childcare facilities, schools and universities were
closed; (2) all non-emergency workers were required to work
from home; (3) gatherings of more than 10 people were banned;
and (4) industrial production was almost at a standstill (3). Rates
of anxiety and depression increased rapidly among the general
population (4, 5).
Preterm birth (PTB) is a significant cause of infant mortality
and morbidity (6). Infants born preterm are at higher risk
for various health problems and developmental delays, often
resulting in emotional and financial difficulties for families and an
increased use of health and social services (7). Previous research
suggests that societal lockdown procedures implemented by
governments to mitigate the impact of the COVID-19 pandemic
on population healthmay result in reduced rates of preterm birth,
particularly among those occurring at very low gestational ages
(8–10). In a US study examining hospital birth data, there was a
significant decrease in the incidence of PTB in 2020 during the
COVID-19 pandemic compared with the rates during the 2019
pre–COVID-19 period (9.9 vs. 12.6%; OR, 0.76; 95% CI, 0.58–
0.99). There was also a significant decrease in PTB at <34 weeks
gestation (2.5 vs. 4.7%; aOR, 0.51; 95% CI, 0.31–0.82) and PTB
at <28 weeks gestation (0.6 vs. 1.5%; aOR, 0.37; 95% CI, 0.15–
0.93) in 2020 compared with the rates in 2019 (9). In an Irish
study where regional data covering most of the 2020 lockdown
period were compared with historical regional and national data,
an unprecedented reduction in births of very low birthweight
(VLBW) and extremely low birthweight (ELBW) infants was
observed coinciding with the COVID-19 lockdown (10). In a
national quasi-experimental study conducted in the Netherlands,
the initial implementation of COVID-19 mitigation measures in
early March 2020 was associated with a substantial reduction
in the incidence of preterm births in the following months (8).
Although these studies have reached similar conclusions, they
only compared the outcomes among pregnant women in their
third trimester during the lockdown period. It remains unknown
whether the pregnancy outcomes of women in their first or
second trimester are affected by the COVID-19 lockdown.
The purpose of this study was to follow uninfected pregnant
women in all three trimesters of pregnancy during the COVID-
19 lockdown in Shanghai to determine whether the lockdown
independently affected PTB rates.
MATERIALS AND METHODS
Patient Enrollment
This retrospective cohort study was conducted at the
International Peace Maternity and Child Health Hospital
(IPMCH), which is a university-affiliated hospital in which
∼20% of all births in Shanghai, China. Eligible pregnant women
were those who had negative nasopharyngeal swab nucleic
acid test when they attended routine obstetrics clinic during
pregnancy and at time of delivery (11); and who received
perinatal healthcare during the lockdown period. Furthermore,
they had to have given birth to an infant with a gestational age
>20 weeks at IPMCH. Women were excluded if they underwent
in vitro fertilization, had a twin or multiple birth and were not of
the Han race. The start of the lockdown in Shanghai was officially
declared on January 24, 2020 (3), and the city-specific lockdown
ended on March 24, 2020, when the Shanghai government
adjusted the public health emergency response from level one to
level two (12).
Data Collection
For all eligible pregnant women, the following data were
collected by hospital staff and recorded in the electronic
medical file: maternal age, marital status, pre-pregnancy body
weight and height, smoking status, current alcohol consumption,
maternal education level, parity, preterm birth history, pregnancy
complications, date of last menstrual period (LMP), paternal
age, paternal education level, neonatal birth weight, Apgar score,
and electronic fetal heart rate monitoring records. Maternal and
paternal educational levels were defined as the years of education
after graduation from primary school and were categorized as<6
years (low), 6 to 10 years (middle) and >10 years (high). Height
and pre-pregnancy weight were used to obtain BMI scores which
calculated by dividing the weight obtained above by the square of
the height and categorized as low weight (<18.5), normal weight
(18.5–23.9), overweight or obese (≥24.0).Marital status, smoking
status and current consumption of alcohol were self-reported
and categorized as yes or no. Parity was defined as the number
of previous pregnancies resulting in at least one live birth, and
was categorized as nulliparous (None) and multiparous (≥1).
Preterm birth history was defined as a history of one or more
live births at <37 weeks of gestation. The gestational age of
all eligible women was estimated according to the date of the
last menstrual period and was adjusted according to routinely
performed ultrasonography in the first trimester. The gestational
phase during the lockdown period induced by the COVID-19
pandemic was defined as (1) first trimester (pregnant women
who were in their first trimester during the lockdown period);
(2) first to second trimester (pregnant women who were in
their first trimester when the lockdown started and were in
second trimester when the lockdown ended); (3) second trimester
(pregnant women who were in their second trimester during
the lockdown period); (4) second to third trimester (pregnant
women who were in their second trimester when the lockdown
started and were in their third trimester when the lockdown
ended); and (5) third trimester (pregnant women who were in
their third trimester during the lockdown period) (Figure 2).
Diagnostic Criteria
In this study, preterm birth (PTB) was defined as a birth before
37 weeks of gestation. Very early preterm birth (VPTB) was
defined as a birth before 34 weeks of gestation. PTB was classified
into spontaneous PTB and medically induced preterm birth (MI-
PTB) according to clinical presentation, and spontaneous PTBs
were further categorized as preterm birth with premature rupture
of membranes (PROM-PTB) or spontaneous preterm birth with
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intact membranes (S-PTB). The classification criteria were as
follows: (1) PROM-PTB was defined as PTB with spontaneous
rupture of the membranes at <37 weeks of gestation and before
the onset of contractions; (2) S-PTB was defined as spontaneous
PTB with intact membranes; and (3) MI-PTB was defined as PTB
after labor induction or cesarean delivery for maternal or fetal
indications (13). Pregnancy complications included gestational
diabetes and pregnancy-induced hypertension. Gestational
diabetes mellitus (GDM) was defined as diabetes diagnosed
in the second or third trimester of pregnancy that was
not clearly identified as overt diabetes prior to gestation
(14). Pregnancy-induced hypertension (PIH) was defined as
systolic blood pressure (SBP) >140 mmHg and diastolic
blood pressure (DBP) >90 mmHg during pregnancy and was
classified into three conditions: (1) gestational hypertension
and preeclampsia (PE); (2) pre-existing hypertension plus
superimposed gestational hypertension with proteinuria; and (3)
unclassifiable hypertension during pregnancy (15). Stillbirth was
defined as a baby born with no signs of life at a gestational
age of 24 weeks or more. Abnormal Apgar score was defined
as a 5-min Apgar score of 7 or less. Fetal distress, also
named as “non-reassuring fetal status” by the recommendation
of ACOG Committee on Obstetrics Practice, was defined as
a pathophysiological condition in which fetus was suffering
from insufficient oxygen supply, which was diagnosed through
electronic fetal heart rate (FHR) monitoring (16). Low birth
TABLE 1 | Baseline characteristics total sample, unweighted sample, propensity score-matched sample, and inverse probability of treatment-weighted sample.
















Age, median (Q1-Q3), y 31 (29–34) 31 (29–34) <0.001 31 (29–34) 31 (29–34) 0.06 31 (29–34) 31 (29–34) <0.001
Marital Status
Married 8,220 (99.4) 9,709 (98.9) 0.001 8,218 (99.4) 8,218 (99.4) 1.00 17,920 (99.1) 17,927 (99.1) 0.54
Single or divorced 50 (0.6) 106 (1.1) 50 (0.6) 50 (0.6) 168 (0.9) 157 (0.9)
Body mass index, median
(Q1–Q3),kg/m2 20.8 (19.3–22.8) 20.7 (19.2–22.6) 0.009 20.8 (19.3–22.8) 20.8 (19.3–22.8) 0.08 20.8 (19.3–22.7) 20.8 (19.3–22.7) <0.001
Body mass index
Low 1,106 (13.4) 1,381 (14.1) 0.02 1,106 (13.4) 1,188 (14.4) 0.07 2,530 (14.0) 2,458 (13.6) 0.25
Normal 5,863 (70.9) 7,026 (71.6) 5,863 (70.9) 5,857 (70.8) 12,808 (70.8) 12,947 (71.6)
Overweight or Obesity 1,301 (15.7) 1,408 (14.3) 1,299 (15.7) 1,223 (14.8) 2,751 (15.2) 2,678 (14.8)
Current smoker (yes) 31 (0.4) 51 (0.6) 0.04 33 (0.4) 42 (0.5) 0.30 106 (0.6) 96 (0.5) 0.48
Current alcohol
consumption (yes)
63 (0.8) 254 (2.6) <0.001 63 (0.8) 69 (0.8) 0.60 319 (1.8) 317 (1.8) 0.94
Education level
Low 610 (7.4) 743 (7.6) <0.001 610 (7.4) 579 (7.0) 0.27 1,447 (8.0) 1,288 (7.1) <0.001
Middle 5,655 (68.4) 6,972 (71.0) 5,655 (68.4) 5,749 (69.5) 12,442 (68.8) 12,762 (70.6)
High 2,005 (24.2) 2,100 (21.4) 2,003 (24.2) 1,940 (23.5) 4,200 (23.2) 4,034 (22.3)
Parity
Nulliparous 5,763 (69.7) 6,789 (69.1) 0.43 5,761 (69.7) 5,730 (69.3) 0.60 12,548 (69.4) 12,547 (69.4) 0.99
Multiparous 2,507 (30.3) 3,029 (30.9) 2,507 (30.3) 2,538 (30.7) 5,541 (30.6) 5,537 (30.6)
Preterm birth history
(yes)
13 (0.2) 55 (0.6) <0.001 13 (0.2) 6 (0.1) 0.11 28 (0.2) 39 (0.2) 0.18
Gestational phase during COVID-19 lockdown
First trimester 280 (3.4) 325 (3.3) 0.001 280 (3.4) 268 (3.2) 0.73 620 (3.4) 592 (3.3) <0.001
First to second trimester 2,088 (25.2) 2,403 (24.5) 2,088 (25.3) 2,060 (24.9) 4,630 (25.6) 4,389 (24.3)
Second trimester 1,313 (15.9) 1,735 (17.7)0 1,313 (15.9) 1,367 (16.5) 2,888 (16.0) 3,181 (17.6)
Second to third trimester 1,942 (23.5) 2,414 (24.6) 1,941 (23.5) 1,968 (23.8) 4,234 (23.4) 4,454 (24.6)
Third trimester 2,647 (32.0) 2,938 (29.9) 2,646 (32.0) 2,605 (31.5) 5,716 (31.6) 5,467 (30.2)
Paternal demographics
Age, median (Q1–Q3), y 32 (30–35) 32 (29–35) <0.001 32 (30–35) 32 (29–35) 0.06 32 (29–35) 32 (29–35) <0.001
Education level
Low 609 (7.4) 718 (7.3) 0.002 609 (7.4) 597 (7.2) 0.07 1,411 (7.8) 1,263 (7.0) 0.001
Middle 5,482 (66.3) 6,734 (68.6) 5,482 (66.3) 5,617 (67.9) 12,050 (66.6) 12,349 (68.3)
High 2,179 (26.3) 2,363 (24.1) 2,177 (26.3) 2,054 (24.8) 4,627 (25.6) 4,473 (24.7)
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weight (LBW) was defined as newborn whose birth weight was
<2,500 g. Very low birth weight (VLBW) was defined as newborn
whose birth weight was <1,500 g. Macrosomia was defined as
newborn whose birth weight was more than 4,000 g.
Statistical Analyses
Considering the differences in baseline characteristics between
the two groups of participants (Table 1), we used propensity
score matching to generate a cohort with similar baseline
characteristics. The propensity score is the conditional
probability of having a specific exposure level (lockdown
vs. non-lockdown) under a given set of baseline covariates
(17, 18). A multivariate logistic regression model was used to
estimate propensity scores, and all baseline characteristics listed
in Table 1 were included as covariates (1) using a 1:1 matching
protocol with no replacement for matching with a caliper width
equal to 0.005 and (2) evaluating the P-values of all baseline
covariates before and after matching to assess whether they were
balanced. Standard differences of <5% indicated a relatively
small imbalance. There were no missing data for the variables in
the matched cohort.
Inverse probability of treatment weighting (IPTW) was
used to investigate the COVID-19 exposure among the
entire population of pregnant women when this population
hypothetically moved from no COVID-19 exposure (non-
lockdown) to exposure (lockdown) in different pregnancy phases.
Participants were weighted by the inverse of the probability
of exposure to the COVID-19 lockdown. The association
between COVID-19 lockdown and PTB was estimated using
the Odds Ratio (OR) obtained from log binomial regression
and the Absolute Risk Difference (ARD) obtained from
identity link binomial regression. In both groups, the IPTW
weights were used with a quasibinomial model to obtain
robust variance estimates. To avoid convergence issues, the
R package glm2 was used. Group differences were assessed
by calculating IPTW proportions, weighted medians, and
standardized mean differences.
The differences in the distribution of maternal characteristics
between lockdown and non-lockdown groups were evaluated
by the chi-square test for categorical variables and the Mann–
Whitney U-test for continuous variables. Time to delivery
was evaluated through Kaplan-Meier estimates, and differences
between the groups were tested with a log rank test. Logistic
regression was performed to calculate crude and adjusted odds
ratios (aORs) and 95% confidence intervals (CIs). Potential
confounders includedmaternal age, parity, preterm birth history,
GDM, PIH, and paternal age. The selection of potential
confounders was based on biological plausibility, identification
of a variable as a confounder in previous studies, changes in
the effect estimate of interest, or reduction in the residual
variability of the outcome. Sensitivity analysis was used to
evaluate the difference in PTB in each subgroup between
the matched lockdown and non-lockdown groups to identify
potential bias. A two-sided P-value of <0.05 was considered
statistically significant. All statistical tests were conducted using
SPSS version 24.0 and R version 3.6.
RESULTS
Baseline Characteristics
A total of 9,213 pregnant women were consecutively enrolled
from January 24th, 2020, to March 24th, 2020 (lockdown), and
FIGURE 1 | Flow chart of the study population.
Frontiers in Medicine | www.frontiersin.org 4 September 2021 | Volume 8 | Article 705943
Lin et al. COVID-19 Lockdown and Preterm Birth
10935 were enrolled from January 24th, 2019, to March 24th,
2019 (non-lockdown). After the implementation of the exclusion
criteria, 8,270 pregnant women in the lockdown group and 9,815
pregnant women in the non-lockdown group remained in the
final study population (Figure 1).
Table 1 shows the baseline characteristics between the two
groups in the unweighted sample analysis, propensity score-
matched analysis, and inverse probability treatment weighting
analysis. Compared with the non-lockdown group, women in
the lockdown group were more likely to be married (99.4 vs.
98.9%, P = 0.001), have a higher BMI (20.8 vs. 20.7 kg/m2, P
= 0.009), have a higher education level (24.2 vs. 21.4%, P <
0.001). They were also less likely to be current smokers (0.4 vs.
0.6%, P = 0.04), have current alcohol consumption (0.8 vs. 2.6%,
P < 0.001) and have a preterm birth history (0.2 vs. 0.6%, P
< 0.001). Through the use of propensity score matching, 8,268
women in the lockdown group were matched with 8,268 women
in the non-lockdown group. After matching, the P-values of all
variables were >0.05, indicating that no significant differences
existed between the two groups. Through the use of IPTW,
marital status, maternal BMI distribution, smoking and alcohol
consumption, and preterm birth history were balanced between
the two groups (Table 1).
Risk of PTB and VPTB in Different
Pregnancy Phases
Although there was no group difference in the prevalence of
PTB (5.7 vs. 5.3%, P = 0.71) or VPTB (1.3 vs. 1.2%, P =
0.78) in the total sample (Supplementary Table 1). Women in
lockdown during their second trimester had a higher rate of PTB
(unweighted sample: 5.9 vs. 4.6%, P= 0.08; matched: 5.9 vs. 4.2%,
P = 0.045; IPTW: 6.0 vs. 4.6%, P = 0.02) (Table 2; Figure 2) and
a non-significantly higher rate of VPTB (unweighted sample: 1.9
vs. 1.4%, P = 0.32; matched: 1.9 vs. 1.2%, P = 0.12; IPTW: 2.0 vs.
1.4%, P= 0.11) (Table 2) than those in the non-lockdown period.
After adjusting for maternal age, parity, GDM, and paternal age,
women in their second trimester during lockdown had a higher
risk of PTB [unweighted sample: OR: 1.34 (CI 0.97–1.86), ARD:
1.3 (CI 0.3–2.9), p = 0.08; matched: OR: 1.43 (CI 1.01–2.02),
ARD: 1.7 (CI 0.04–3.4), p = 0.045; IPTW: OR: 1.32 (CI 1.05–
1.65), ARD: 1.4 (CI 0.3–2.5), p = 0.02] (Table 2) and a non-
significantly higher risk of VPTB [unweighted sample: OR: 1.33
(CI 0.76–2.32), ARD: 0.5 (CI−0.4 to 1.4), p= 0.32; matched: OR:
1.63 (CI 0.85–3.12), ARD: 0.7 (CI −0.2 to 1.6), P = 0.14; IPTW:
OR: 1.37 (CI 0.93–2.03), ARD: 0.6 (CI −0.05 to 1.3), p = 0.11]
than those in non-lockdown cohort (Table 2). There were no
significant differences between the two groups in PTB or VPTB
rates during the other pregnancy phases (first, first to second,
second to third and third trimesters) (Supplementary Table 2).
The Association Between COVID-19
Lockdown and Subtypes of PTB in
Different Pregnancy Phases
We further explored the risk of different clinical subtypes of
PTB (PROM-PTB, S-PTB, andMI-PTB) associated with COVID-
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FIGURE 2 | Kaplan-Meier Curve for Lockdown and Non-Lockdown Groups in Propensity-Score-Matched Cohort and the Definition of Different Pregnancy Phases.
This figure shows the probability of delivery among pregnant women who were in different pregnancy phases during Lockdown period in two groups. P-values were
calculated through log rank test. The small picture in each picture is a partial enlarged picture of 28–37 weeks of gestation. (A), Pregnant women who were in First
trimester during Lockdown period. (B), Pregnant women who were in First to Second trimester during Lockdown period. (C). Pregnant women who were in Second
trimester during Lockdown period. (D). Pregnant women who were in Second to Third trimester during Lockdown period. (E). Pregnant women who were in Third
trimester during Lockdown period. (F) The definition of different pregnancy phases.
of PROM-PTB in the third trimester among women in
lockdown was higher than that among those in non-lockdown
(unweighted sample: 2.3 vs. 1.5%, P = 0.04; matched: 2.3 vs.
1.4%, P = 0.02; IPTW: 2.3 vs. 1.5%, P = 0.003) (Table 2;
Supplementary Figure 1). After adjusting for maternal and
paternal age and parity, among pregnant women in their third
trimester, those in lockdown had an increased risk of PROM-
PTB compared to those in non-lockdown [unweighted sample:
OR: 1.52 (CI 1.03–2.24), ARD: 0.8 (CI 0.08–1.5), P = 0.04;
matched: OR: 1.64 (CI 1.09–2.47), ARD: 0.9 (CI 0.2–1.6), p =
0.02; IPTW: OR: 1.51 (CI 1.14–1.99), ARD: 0.8 (CI 0.3–1.3),
P = 0.003] (Table 2). The pregnant women in lockdown during
their third trimester did not have an increased risk of S-PTB
or MI-PTB in the three types of analysis (Table 2). There were
no significant differences between the two groups in PROM-
PTB, S-PTB, or MI-PTB rates in the other pregnancy phases
(first, first to second, second and second to third trimesters)
(Supplementary Figure 1; Supplementary Table 3).
Sensitivity Analyses
In sensitivity analyses, we divided pregnant women during their
second trimester into a propensity score-matched cohort based
on whether they had GDM, which resulted in 1,195 pregnant
women without GDM and 172 with GDM in the non-lockdown
group and 1,102 women without GDM and 211 with GDM
in the lockdown group. The association between lockdown
and PTB did not change substantially (Supplementary Table 4;
Supplementary Figure 2). After adjusting for maternal and
paternal age, and parity, pregnant women without or with GDM
in lockdown had a higher risk of PTB [without GDM: OR:
1.27 (CI 0.86–1.88), p = 0.24; with GDM: OR: 1.73 (CI 0.68–
4.40), p = 0.25] and VPTB [without GDM: OR: 1.55 (CI 0.77–
3.11), p = 0.22; with GDM: OR: 3.27 (CI 0.46–23.28), p = 0.24]
than those in non-lockdown, although the results did not reach
statistical significance (Supplementary Table 4). Similar results
were also found in the unweighted sample and through the use of
IPTW (Supplementary Table 4). We also performed sensitivity
analyses for the association between COVID-19 lockdown and
PROM-PTB rates among pregnant women with or without
GDM during their third trimester in the propensity score-
matched cohort. Pregnant women in lockdown during their third
trimester, with or without GDM, had a higher risk of PROM-PTB
[without GDM: OR: 1.70 (CI 1.08–2.69), p = 0.02; with GDM:
OR: 1.05 (CI 0.37–2.97), p = 0.94] than those in non-lockdown
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in the propensity score-matched analysis. Similar results were
found in the unweighted sample and through the use of IPTW
(Supplementary Table 5; Supplementary Figure 3).
DISCUSSION
This is the first study to examine the relationship between the
COVID-19 lockdown and preterm birth among women who
were affected by the lockdown in different trimesters. We found
that exposure to the COVID-19 lockdown did not reduce, but
increased the risk of PTB among pregnant women in their second
trimester and increased the risk of PROM-PTB among those in
their third trimester.
Previous evidence suggests that the COVID-19 pandemic and
the lockdown measures taken by governments to mitigate its
impact on population health were associated with reductions
in PTBs (8–10, 19). However, these studies focused on the
outcomes of pregnant women who were in their third trimester
during the COVID-19 lockdown. In our study, we found that
the PTB rate was stable among women in their third trimester,
which is consistent with a retrospective study conducted in
the United Kingdom (20). The difference with previous studies
may be attributed to race and the national attitude toward
the COVID-19 pandemic and need for lockdown measures.
We further explored the impact of the COVID-19 lockdown
on women during early or middle pregnancy and found that
exposure to the lockdown led to a 1.42-fold risk of PTB
among women in the second trimester and a 1.64-fold risk of
PROM-PTB among women in the third trimester. Lockdown
measures have a significant societal impact, as they lead to
an increased risk for unemployment, low-income status, and
family conflicts (21). These factors increase a pregnant woman’s
risk for anxiety and depression (21). Anxiety has been shown
to enhance hypothalamus-pituitary-adrenal cortex (HPA) axis
activity (22, 23). Studies have demonstrated that the levels of
corticotropin-releasing hormone (CRH), which is released when
anxiety stimulates the HPA axis, are significantly higher in
women who have delivered a preterm infant than in those who
gave birth at term (24). Alternatively, the increase in PTB rates
among women exposed to the lockdown may have resulted
from indirect effects such as reluctance to go to the hospital
when needed (e.g., reduced fetal movements or mild vaginal
infection) due to a fear of developing a COVID-19 infection or
not wanting to increase the burden on the health care system
(20). Changes in obstetrical care may also have played a role
in the higher rates of PTB due to staff shortages and reduced
number of antenatal visits, ultrasound scans, and screening
procedures (25). It was consistent with the finding of a systematic
review, in which the incidence of preterm birth occurred was
similar among pregnant women who tested positive compared
with negative for SARS-CoV-2 (26). The preterm birth rates
in this review were thought influenced by transient changes
in obstetric management (26). Other possible explanations for
our findings include (1) changes in referral methods where
more high-risk women were sent to the participating hospital
or (2) more high-risk women choosing to deliver at the larger
more specialized hospital (20). It is important to provide quality
obstetric services that also included the effective management
of anxiety and depression to try and mitigate the risk for
preterm birth.
Our study has numerous strengths. This study provides the
first evidence that the effects of the COVID-19 lockdown on
the preterm birth rate have a trimester difference. Second, we
used several statistical methods (unweighted sample, propensity
score matching, and IPTW) to examine the association between
exposure to the COVID-19 lockdown and risk for a PTB
to ensure the accuracy of the study results. Some limitations
also exist. First, we did not confirm the mental health status
of participants during the COVID-19 lockdown. However,
another study by our team evaluated the mental health of
pregnant women in 25 hospitals in China before and during
the pandemic and found significantly higher rates of depression
and anxiety among those who were pregnant during the
COVID-19 lockdown (23). Second, some pregnant women in
their early pregnancy during the COVID-19 pandemic had
not yet given birth when we completed the data analysis.
As such, the sample size for those in their first trimester
was slightly smaller. Furthermore, the number of gestational
weeks for women examined in their first trimester was lower
than that of those examined in other trimesters. Thus, those
examined in their first trimester who had given birth and
were included in our analyses were naturally more likely
to have delivered a preterm infant. This explains why the
PTB rate among women examined in their first trimester
was higher than that among those examined later in their
pregnancy. Last, although we controlled for as many PTB
confounding factors as possible, there may be other unmeasured
confounders that could have caused bias in our propensity score-
matched cohort.
This is the first study to explore the relationship between
COVID-19 lockdown and PTB among non-infected women
in different trimesters. Different from previous research
conclusions, our study suggests that women in their second
trimester during the COVID-19 lockdown were at an increased
risk for PTB and that those in their third trimester were
at an increased risk for PROM-PTB. Sufficient prenatal
care and education program should be emphasized for
pregnant women during any society lockdown and warrant
additional research.
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